Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 18, 2023

BUY
$191.89 - $259.92 $10,362 - $14,035
54 Added 10.42%
572 $115 Million
Q4 2022

Feb 09, 2023

BUY
$197.11 - $250.07 $102,102 - $129,536
518 New
518 $113 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track New Hampshire Trust Portfolio

Follow New Hampshire Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Hampshire Trust, based on Form 13F filings with the SEC.

News

Stay updated on New Hampshire Trust with notifications on news.